Paradromics received regulatory approval to test its BCI device in a small clinical trial to assess its safety and efficacy.

Telco extends presence in API arena with two products designed to give businesses practical tools to improve customer experience, while laying the foundation for models of innovation and collaboration ...

A New York-based biotech firm announced it has raised an additional $200 million in financing to advance commercialization of ...

Paradromics Inc., a neurotechnology company developing the highest data-rate brain-computer interface (BCI) platform, today announced the US FDA has granted Investigational Device Exemption (IDE) ...

The 2025 Research Innovation Grants are supporting projects focused on biomarkers, risk factors, and treatments for ALS.

Abby Stylianou built an app that asks its users to upload photos of hotel rooms they stay in when they travel. It may seem ...

Synchron successfully implanted the first FDA-approved brain-computer interface in a U.S. patient with ALS. The device ...

Austin-based neurotechnology Paradromics announced that it has received FDA approvals to start its clinical trials.

Powerful artificial intelligence (AI) systems, like ChatGPT and Gemini, simulate understanding of comedy wordplay, but never ...

Paradromics announced that it received FDA investigational device exemption (IDE) to begin a study of its brain-computer ...

A paralyzed man has become the first person to operate an iPad using only his thoughts. The breakthrough arrived through a ...